FCP
CME icon

Fidelis Capital Partners’s CME Group CME Stock Holding History

Fidelis Capital Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$500K Buy
1,694
+101
+6% +$30K 0.04% 319
2025
Q4 		$435K Buy
1,593
+224
+16% +$60.9K 0.03% 338
2025
Q3 		$370K Buy
1,369
+108
+9% +$29.4K 0.03% 355
2025
Q2 		$355K Buy
1,261
+57
+5% +$15.5K 0.03% 319
2025
Q1 		$321K Buy
1,204
+111
+10% +$27.4K 0.03% 310
2024
Q4 		$263K Buy
1,093
+126
+13% +$29K 0.03% 361
2024
Q3 		$220K Buy
+967
New +$200K 0.03% 376
2024
Q2 		– Sell
-936
Closed -$202K – 382
2024
Q1 		$202K Sell
936
-739
-44% -$155K 0.03% 355
2023
Q4 		$353K Buy
1,675
+275
+20% +$58.7K 0.08% 220
2023
Q3 		$280K Buy
1,400
+52
+4% +$10.3K 0.1% 203
2023
Q2 		$250K Buy
1,348
+176
+15% +$32.5K 0.09% 229
2023
Q1 		$217K Buy
+1,172
New +$212K 0.09% 224

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelis Capital Partners's CME Position: Q1 2026 in Review

Fidelis Capital Partners increased its CME Group (CME) stake by 6.3% in Q1 2026, buying an estimated $30K and bringing the position to 1,694 shares worth $500K. The position accounts for 0.04% of the portfolio, ranked #319.

Fidelis Capital Partners first reported a position in CME in Q1 2023 and has held it in 12 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Fidelis Capital Partners held 1,694 shares of CME Group worth $500K as of Q1 2026.
  • Fidelis Capital Partners bought 101 CME Group shares in Q1 2026, an estimated $30K.
  • CME Group made up 0.04% of Fidelis Capital Partners's portfolio in Q1 2026, its #319 holding.
  • Fidelis Capital Partners first reported a position in CME Group in Q1 2023 and has held it in 12 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.